In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.